Skip to main content
Have a personal or library account? Click to login
BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers Cover

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers

Balkan Journal of Medical Genetics
Volume 25 (2022): Issue 2 (December 2022)
By: ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,   and    
Open Access
|May 2023
Authors

Authors

K. Osman

osmankostek@hotmail.com

Marmara University, School of Medicine, Department of Medical Oncology, İstanbul, Turkey

K. Ahmet

Trakya University, Department of Medical Oncology, Edirne, Turkey

T. Hilmi

Namık Kemal University, Department of Medical Genetic, Tekirdag, Turkey

N.O. İlker

Medeniyet University, Department of Medical Oncology, İstanbul, Turkey

Ö. Ercan

Kocaeli University, Department of Medical Oncology, Kocaeli, Turkey

Ç. Devrim

Kocaeli University, Department of Medical Oncology, Kocaeli, Turkey

S. Murat

Marmara University, School of Medicine, Department of Medical Oncology, İstanbul, Turkey

Ç. Emre

Sakarya University, Department of Medical Oncology, Sakarya, Turkey

H. İlhan

Sakarya University, Department of Medical Oncology, Sakarya, Turkey

G. Mustafa

Ankara university, Department of Medical Oncology, Ankara, Turkey

Ü. Yüksel

Ankara university, Department of Medical Oncology, Ankara, Turkey

Y. Bahiddin

Ondokuz Mayıs University, Department of Medical Oncology, Samsun, Turkey

E. Cihan

Ankara City Hospital, Yildirim Beyazit University, Department of Medical Oncology, Ankara, Turkey

N. Ş. Mehmet Ali

Ankara City Hospital, Yildirim Beyazit University, Department of Medical Oncology, Ankara, Turkey

E. Emrah

University of Health Sciences, Dr. A.Y Ankara Oncology Research and Education Hospital, Oncology Department, Ankara, Turkey

D. Umut

University of Health Sciences, Dr. A.Y Ankara Oncology Research and Education Hospital, Oncology Department, Ankara, Turkey

O. Zeynep

Dicle University, Department of Medical Oncology, Diyarbakır, Turkey

K. Mehmet Ali

Trakya University, Department of Medical Genetic, Edirne, Turkey

G. Ali

Trakya University, Department of Medical Oncology, Edirne, Turkey

G. İvo

Trakya University, Department of Medical Oncology, Edirne, Turkey

Ö. Erkan

Trakya University, Department of Medical Oncology, Edirne, Turkey

B.H. Muhammet

Trakya University, Department of Medical Oncology, Edirne, Turkey

E. Bülent

Trakya University, Department of Medical Oncology, Edirne, Turkey

D. Selma

Trakya University, Department of Medical Genetic, Edirne, Turkey

U. Sernaz

Trakya University, Department of Medical Oncology, Edirne, Turkey

G. Mahmut

Medeniyet University, Department of Medical Oncology, İstanbul, Turkey

G. Hakan

Trakya University, Department of Medical Genetic, Edirne, Turkey

Ç. İrfan

Trakya University, Department of Medical Oncology, Edirne, Turkey
DOI: https://doi.org/10.2478/bjmg-2022-0023 | Journal eISSN: 2199-5761
Journal RSS Feed
Language: English
Page range: 5 - 14
Published on: May 2, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
BRCA 1,
BRCA 2,
breast,
pancreas,
genital cancers,
prostate,
pancreas
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2023 K. Osman, K. Ahmet, T. Hilmi, N.O. İlker, Ö. Ercan, Ç. Devrim, S. Murat, Ç. Emre, H. İlhan, G. Mustafa, Ü. Yüksel, Y. Bahiddin, E. Cihan, N. Ş. Mehmet Ali, E. Emrah, D. Umut, O. Zeynep, K. Mehmet Ali, G. Ali, G. İvo, Ö. Erkan, B.H. Muhammet, E. Bülent, D. Selma, U. Sernaz, G. Mahmut, G. Hakan, Ç. İrfan, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 25 (2022): Issue 2 (December 2022)
Next article